For Novavax, Building Trust Was Key To Improving Diversity

Company Took Lead In Native American Vaccine Study Enrollment

Novavax’s Lisa Dunkle talked to Scrip about the time and effort that went into building trust among Native American communities to encourage participation in its COVID-19 vaccine study.

COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
Novavax relied on building trust to increase diversity in its COVID-19 vaccine trial • Source: Shutterstock

More from Diversity & Inclusion

More from ESG